| | | | | | | |
 | CSL LIMITED | -1.23% | 6.46% | 7.06% | 19.04% | -3.91% | 103 363 |
 | SAMSUNG BIOLOGICS CO.,LTD. | 0.74% | 1.12% | -0.97% | 5.72% | 56.65% | 45 550 |
 | BIOGEN INC. | 1.17% | -2.22% | 5.32% | 31.79% | -13.89% | 41 513 |
 | WUXI BIOLOGICS (CAYMAN) INC. | 1.50% | -5.22% | 7.69% | -18.98% | 81.21% | 34 193 |
 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. | -0.71% | -1.90% | 8.28% | -9.96% | 44.90% | 22 564 |
| BIOMARIN PHARMACEUTICAL INC. | -0.93% | -4.32% | 7.39% | 24.36% | 28.38% | 20 849 |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. | 1.15% | -3.50% | 2.72% | -15.74% | --.--% | 17 164 |
 | UCB | -0.18% | 1.38% | 3.51% | -14.39% | -12.54% | 15 557 |
| WALVAX BIOTECHNOLOGY CO., LTD. | 0.05% | -1.81% | -1.59% | -17.95% | 37.42% | 9 308 |
| BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | 0.67% | -2.12% | -7.66% | 4.19% | 50.36% | 8 790 |
| INNOVENT BIOLOGICS, INC. | 0.82% | -4.68% | 28.66% | 37.92% | 34.06% | 8 360 |
| CELLTRION HEALTHCARE CO., LTD. | 0.67% | -1.00% | 2.93% | -3.89% | 9.67% | 7 586 |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | 2.51% | -3.82% | -20.10% | -12.92% | 62.13% | 7 334 |
 | SWEDISH ORPHAN BIOVITRUM AB (PUBL) | -0.13% | 1.90% | 9.27% | 26.25% | 34.11% | 6 580 |
| SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. | -0.81% | -2.23% | -3.31% | -8.92% | -38.33% | 6 134 |
| | | | | | | |
| | Gemiddelde | 0.35% | -1.46% | 3.28% | 3.10% | 26.44% | |
| | Gewogen gemiddelde per kap. | 0.05% | 0.47% | 4.74% | 8.09% | 21.85% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
